MarketLens
Sign Up

What's Behind Clene's Recent Stock Volatility and Insider Sales

3 months ago
SHARE THIS ON:

What's Behind Clene's Recent Stock Volatility and Insider Sales

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News1 week ago

Insider Cuts Holdings of Growth Stock Following 78% Rally

An insider trimmed an 11% direct stake in a growth stock after a 78% rally, retaining 22,014 shares worth $2.4 million. The sale follows a sharp run-up, potentially signaling reduced conviction at cur...
Stock News1 week ago

NeOnc Technologies- Talk Is Cheap, Insider Buying Isn't

NeOnc Technologies CEO Amir Heshmatpour bought 15,000 NTHI shares on August 14–17 at $3.79–$4.37, signaling insider confidence amid ongoing open-market purchases.
Stock News2 weeks ago

Clene Targets Early Q4 NDA Filing for CNM-Au8 in ALS

Clene (NASDAQ: CLNN) plans to submit an NDA in early Q4 for CNM-Au8 in ALS, following FDA meetings. The filing could set up a potential approval decision and commercial launch if the agency accepts th...

Breaking News

View All →

Top Headlines

View More →
Stock News4 hours ago

The Biggest Risk Facing Tesla Stock Right Now

Stock News6 hours ago

Microsoft Among 14 Dividend Growth Companies To Announce Annual Dividend Increases In September

Stock News8 hours ago

Nvidia Just Delivered Bad News for AMD and Intel

Stock News9 hours ago

Microsoft: A High-Quality AI Name That Is No Longer Misunderstood

Stock News9 hours ago

Meta Stock Looks Undervalued. Is the Market Missing Something?